May 6, 2026 04:07PM
Apr 16, 2026 08:06AM
Mar 4, 2026 06:43AM
Feb 26, 2026 01:07PM
Feb 24, 2026 07:05AM
Feb 24, 2026 06:05AM
Feb 24, 2026 05:47AM Vir Biotechnology (VIR) PT Raised to $18 at Evercore ISI
Feb 23, 2026 05:25PM
Feb 23, 2026 05:15PM
Feb 23, 2026 05:01PM
Jan 12, 2026 08:07AM
Dec 30, 2025 06:38AM
Dec 17, 2025 07:04AM
Dec 16, 2025 04:06PM Vir Biotechnology grants Norgine exclusive license for hepatitis delta treatment
Dec 9, 2025 04:24AM
Nov 5, 2025 04:20PM
Oct 7, 2025 08:04AM
Sep 16, 2025 06:55AM
Sep 3, 2025 05:15AM
Aug 27, 2025 06:09AM
Aug 6, 2025 04:10PM Vir Biotechnology Inc. (VIR) Misses Q2 EPS by 10c, provides guidance
Aug 6, 2025 08:06AM
Jul 31, 2025 08:06AM
May 20, 2025 06:38AM
May 7, 2025 04:13PM
Mar 13, 2025 10:06AM
Feb 26, 2025 04:14PM
Jan 30, 2025 07:54AM Vir Biotechnology Inc. (VIR) Announces CTO Departure
Jan 9, 2025 04:25AM
Jan 8, 2025 04:01PM
Jan 8, 2025 01:27PM
Jan 8, 2025 11:18AM
Jan 8, 2025 07:46AM
Jan 8, 2025 07:46AM
Dec 12, 2024 04:07PM Vir Biotechnology (VIR) Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta
Dec 2, 2024 04:41PM
Nov 20, 2024 07:51AM
Nov 18, 2024 04:06PM
Nov 15, 2024 11:00AM
Oct 31, 2024 04:10PM
Oct 15, 2024 08:16AM
Sep 10, 2024 08:05AM Vir Biotechnology (VIR) Appoints Jason O’Byrne as CFO
Sep 9, 2024 04:39PM
Sep 9, 2024 04:13PM
Aug 20, 2024 06:45AM
Aug 1, 2024 04:24PM
Aug 1, 2024 04:14PM
Aug 1, 2024 04:00PM
Jun 26, 2024 08:05AM Vir Biotechnology (VIR) Receives FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection

401,763 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All